The Interventional Glaucoma Podcast
Join global thought leaders as they engage in unscripted discussions about the latest innovations in Interventional Glaucoma; an inspiring and thought-provoking mindset that prioritizes patient-centered care and challenges ophthalmologists to rethink their treatment strategies. Brought to you by Elios Vision.
Listen on:
Episodes
Tuesday Mar 12, 2024
Tuesday Mar 12, 2024
If the basic concept that impairment in aqueous humor outflow results in elevation of the IOP is a central tenet of glaucoma pathology and treatment; what three facts should all ophthalmologists know about aqueous humor dynamics? Dr. Ike Ahmed and Professor Gus Gazzard sit down with Professor Carl Sheridan to answer this question. They highlight the clinical implications of understanding these dynamics while emphasizing the importance of early intervention and tissue preservation.
Tuesday Mar 12, 2024
Tuesday Mar 12, 2024
Dr. Ike Ahmed and Professor Gus Gazzard are joined by Professor Carl Sheridan to discuss the complexities of the trabecular meshwork and its significance in glaucoma management. They deconstruct some common myths and misconceptions surrounding the structure, and explore the importance of early intervention and precision treatments in obtaining maximum preservation.
Tuesday Mar 12, 2024
Tuesday Mar 12, 2024
Professor Gus Gazzard is joined by Ahmad Elsahn to delve into the use of excimer laser technology and its impact in shifting mindsets towards more interventional strategies for glaucoma patients. They provide insights into the distinct characteristics of the excimer laser, and discuss the safety and efficacy of the treatment.
Tuesday Mar 12, 2024
Tuesday Mar 12, 2024
Dr. Ike Ahmed and Professor Gus Gazzard kick off the Interventional Glaucoma podcast series with an unscripted discussion about the evolving mindset of interventional glaucoma. They explore the motivations behind this shift, including the need to address the limitations of current treatments, and highlight cataract surgery as an opportune entry point to intervene with simultaneous glaucoma treatment.